Showing results (851-860 of 15,775) with videos related to

Sort By:
Pageof 1,578
The Journal of Antimicrobial Chemotherapy|October 7, 2009
The in-vitro properties of ceftazidimeP B Harper
The Journal of Antimicrobial Chemotherapy|October 7, 2009
The in-vitro activity of ceftazidime: comparison with other beta-lactam antibioticsR Vanhoof, B Gordts, H Coignau, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2009
Comparative in-vitro activity of ceftazidime (GR-20263) and other beta-lactamase stable cephalosporins against anaerobic bacteriaA W Chow, K H Bartlett
The Journal of Antimicrobial Chemotherapy|October 7, 2009
Bactericidal activity of ceftazidime against Pseudomonas aeruginosa under conditions simulating serum pharmacokineticP M Shah
The Journal of Antimicrobial Chemotherapy|October 7, 2009
Influence of bacterial beta-lactamase production on susceptibility in agar or broth to new cephalosporinsL Adamsson, K Dornbusch, H O Hallander
The Journal of Antimicrobial Chemotherapy|October 7, 2009
Assay of ceftazidime in biological fluids using high-pressure liquid chromatographyJ Ayrton
The Journal of Antimicrobial Chemotherapy|October 7, 2009
Trial of ceftazidime efficacy in respiratory infections at two dose levelsH Feist, N Vetter, F Muhar, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2009
Evaluation of ceftazidime in the treatment of severe infectionP Zuccoli, I Ho, M Mergoni, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2009
Comparative in-vitro activity of ceftazidime (GR 20263) and other beta-lactamase stable cephalosporins against pseudomonas. Effect of inoculum size and divalent cation supplementationA W Chow, K H Bartlett
The Journal of Antimicrobial Chemotherapy|October 8, 2009
Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatmentVivek Verma, Kusum Harjai, Sanjay Chhibber
Pageof 1,578